Biogenix Molecular is a clinical research site located in Miami, Florida, United States 33165.
Crixeo Clinical Trials Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Biogenix Molecular has participated in 9 clinical trials with 3 currently active.
Therapeutic areas: Small Cell Lung Cancer Extensive Stage, Merkel Cell Carcinoma, Neuroendocrine Tumors Unresectable.
Sponsors: Ariceum Therapeutics GmbH, Perspective Therapeutics, Pfizer.
Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Biogenix Molecular has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Biogenix Molecular has 9 clinical trials on record, with 3 currently active. Their work covers Small Cell Lung Cancer Extensive Stage, Merkel Cell Carcinoma, Neuroendocrine Tumors Unresectable.
Biogenix Molecular has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.